Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups

	Description
Hypertensive Patients With Micardis Plus for the First Time	In Post Marketing Surveillance (PMS), there are totally three figures. The number of enrolled patients: 6,901/ The number of patients for safety assessment: 6,606/ The number of patients for efficacy assessment: 6,120.

Participant Flow:   Overall Study

	Hypertensive Patients With Micardis Plus for the First Time
STARTED	6901
COMPLETED	6120
NOT COMPLETED	781
Micardis+ before the date of contract	201
duplicated subjects	68
no start date of the treatment	20
Micardis Plus before diagnosed date	6
no blood pressure recorded	226
unknown measuring date of BP	118
unable to evaluate	104
no recorded efficacy date	34
inconsistent BP measuring date	4

Reporting Groups

	Description
Hypertensive Patients With Micardis Plus for the First Time	In Post Marketing Surveillance (PMS), there are totally three figures. The number of enrolled patients: 6,901/ The number of patients for safety assessment: 6,606/ The number of patients for efficacy assessment: 6,120.

Baseline Measures

	Hypertensive Patients With Micardis Plus for the First Time
Number of Participants   [units: participants]	6606
Age   [units: years] Mean ± Standard Deviation	59 ± 12
Gender[1] [units: participants]
Female	3506
Male	3080

1.  Primary:

Change From Baseline in SBP (Systolic Blood Pressure) at Week 2   [ Baseline and 2 weeks ]

2.  Primary:

Change From Baseline in DBP (Diastolic Blood Pressure) at Week 2   [ Baseline and 2 weeks ]